vs
Side-by-side financial comparison of Cue Biopharma, Inc. (CUE) and SmartRent, Inc. (SMRT). Click either name above to swap in a different company.
SmartRent, Inc. is the larger business by last-quarter revenue ($36.5M vs $21.9M, roughly 1.7× Cue Biopharma, Inc.). Cue Biopharma, Inc. runs the higher net margin — 7.2% vs -8.9%, a 16.1% gap on every dollar of revenue. On growth, Cue Biopharma, Inc. posted the faster year-over-year revenue change (1292.3% vs 3.1%). Over the past eight quarters, Cue Biopharma, Inc.'s revenue compounded faster (257.5% CAGR vs -15.0%).
Cue Biopharma is a clinical-stage biotechnology company focused on developing novel targeted immunotherapies for cancer, autoimmune disorders, and inflammatory diseases. Its proprietary platform enables precise T-cell activity modulation, with core operations in North America and global pharma partnerships to advance lead product candidates through clinical trials.
Budget Rent a Car System, Inc. is an American car rental company that was founded in 1958 in Los Angeles, California by Morris Mirkin. Budget is a subsidiary of the Avis Budget Group, with its operations headquartered in Parsippany, New Jersey.
CUE vs SMRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.9M | $36.5M |
| Net Profit | $1.6M | $-3.2M |
| Gross Margin | — | 38.6% |
| Operating Margin | 9.0% | -10.9% |
| Net Margin | 7.2% | -8.9% |
| Revenue YoY | 1292.3% | 3.1% |
| Net Profit YoY | 116.7% | 71.6% |
| EPS (diluted) | $0.05 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.9M | $36.5M | ||
| Q3 25 | $2.1M | $36.2M | ||
| Q2 25 | $3.0M | $38.3M | ||
| Q1 25 | $421.0K | $41.3M | ||
| Q4 24 | $1.6M | $35.4M | ||
| Q3 24 | $3.3M | $40.5M | ||
| Q2 24 | $2.7M | $48.5M | ||
| Q1 24 | $1.7M | $50.5M |
| Q4 25 | $1.6M | $-3.2M | ||
| Q3 25 | $-7.4M | $-6.3M | ||
| Q2 25 | $-8.5M | $-10.9M | ||
| Q1 25 | $-12.3M | $-40.2M | ||
| Q4 24 | — | $-11.4M | ||
| Q3 24 | $-8.7M | $-9.9M | ||
| Q2 24 | $-10.2M | $-4.6M | ||
| Q1 24 | $-12.3M | $-7.7M |
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 26.4% | ||
| Q2 25 | — | 33.1% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | — | 28.7% | ||
| Q3 24 | — | 33.2% | ||
| Q2 24 | — | 35.7% | ||
| Q1 24 | — | 38.5% |
| Q4 25 | 9.0% | -10.9% | ||
| Q3 25 | -353.4% | -19.4% | ||
| Q2 25 | -292.3% | -30.5% | ||
| Q1 25 | -2921.4% | -99.9% | ||
| Q4 24 | — | -36.6% | ||
| Q3 24 | -264.2% | -29.0% | ||
| Q2 24 | -390.6% | -14.3% | ||
| Q1 24 | -737.8% | -20.1% |
| Q4 25 | 7.2% | -8.9% | ||
| Q3 25 | -346.6% | -17.3% | ||
| Q2 25 | -287.1% | -28.3% | ||
| Q1 25 | -2911.4% | -97.2% | ||
| Q4 24 | — | -32.3% | ||
| Q3 24 | -259.6% | -24.5% | ||
| Q2 24 | -382.7% | -9.5% | ||
| Q1 24 | -719.1% | -15.2% |
| Q4 25 | $0.05 | $-0.02 | ||
| Q3 25 | $-0.07 | $-0.03 | ||
| Q2 25 | $-0.09 | $-0.06 | ||
| Q1 25 | $-0.17 | $-0.21 | ||
| Q4 24 | — | $-0.06 | ||
| Q3 24 | $-0.17 | $-0.05 | ||
| Q2 24 | $-0.20 | $-0.02 | ||
| Q1 24 | $-0.25 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.1M | $104.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $26.4M | $232.1M |
| Total Assets | $42.2M | $320.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.1M | $104.5M | ||
| Q3 25 | $11.7M | $100.0M | ||
| Q2 25 | $27.5M | $105.0M | ||
| Q1 25 | $13.1M | $125.6M | ||
| Q4 24 | $22.5M | $142.5M | ||
| Q3 24 | $32.4M | $163.4M | ||
| Q2 24 | $30.0M | $187.4M | ||
| Q1 24 | $41.0M | $204.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.0M | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $3.0M | — |
| Q4 25 | $26.4M | $232.1M | ||
| Q3 25 | $13.2M | $234.4M | ||
| Q2 25 | $18.2M | $238.8M | ||
| Q1 25 | $6.6M | $250.7M | ||
| Q4 24 | $17.5M | $289.4M | ||
| Q3 24 | $25.4M | $305.1M | ||
| Q2 24 | $21.6M | $329.4M | ||
| Q1 24 | $30.0M | $333.1M |
| Q4 25 | $42.2M | $320.9M | ||
| Q3 25 | $31.6M | $335.8M | ||
| Q2 25 | $40.7M | $354.0M | ||
| Q1 25 | $22.3M | $366.1M | ||
| Q4 24 | $32.2M | $420.2M | ||
| Q3 24 | $44.8M | $448.6M | ||
| Q2 24 | $42.3M | $475.3M | ||
| Q1 24 | $54.0M | $485.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.09× | — | ||
| Q1 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $7.7M |
| Free Cash FlowOCF − Capex | — | $7.7M |
| FCF MarginFCF / Revenue | — | 21.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.68× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-25.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | $7.7M | ||
| Q3 25 | $-9.0M | $-2.1M | ||
| Q2 25 | $-3.4M | $-14.9M | ||
| Q1 25 | $-8.2M | $-12.2M | ||
| Q4 24 | $-36.3M | $-12.0M | ||
| Q3 24 | $-7.5M | $-3.7M | ||
| Q2 24 | $-10.0M | $-13.9M | ||
| Q1 24 | $-9.8M | $-3.3M |
| Q4 25 | — | $7.7M | ||
| Q3 25 | — | $-2.2M | ||
| Q2 25 | $-3.4M | $-16.2M | ||
| Q1 25 | $-8.3M | $-14.3M | ||
| Q4 24 | $-36.4M | $-13.3M | ||
| Q3 24 | $-7.5M | $-3.9M | ||
| Q2 24 | $-10.0M | $-14.1M | ||
| Q1 24 | $-9.8M | $-3.4M |
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | -6.1% | ||
| Q2 25 | -116.5% | -42.3% | ||
| Q1 25 | -1976.7% | -34.7% | ||
| Q4 24 | -2309.3% | -37.5% | ||
| Q3 24 | -225.7% | -9.7% | ||
| Q2 24 | -376.2% | -29.1% | ||
| Q1 24 | -573.0% | -6.7% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.9% | 3.3% | ||
| Q1 25 | 35.6% | 5.3% | ||
| Q4 24 | 4.2% | 3.5% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.4% | 0.5% | ||
| Q1 24 | 3.2% | 0.1% |
| Q4 25 | -0.68× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CUE
| Immuno Scape Collaboration And License Agreement | $9.5M | 43% |
| BI Collaboration And License Agreement | $8.1M | 37% |
| Other | $4.3M | 20% |
SMRT
| Hosted Services | $18.1M | 50% |
| Hardware Service | $12.5M | 34% |
| Smart Operations Solutions | $2.6M | 7% |
| Access Control | $2.0M | 5% |
| Other Smart Communities Solutions | $1.3M | 3% |
